ftInvstr
NGLFINE · Healthcare ₹2900.0 -3.14% Mkt Cap ₹1804 Cr

NGLFINE

Healthcare Drug Manufacturers - General
₹2900.0
-3.14% today · 30d -14.2%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for NGLFINE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹139 Cr
+33.57% YoY
NET PROFIT
₹18 Cr
+99.09% YoY
OPM
20.95%
+5.28pp YoY
EPS
₹29.78
PE 30.98
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
NGLFINE30.989.0
GLAXO46.8657.97
RUBICON101.0127.36
PFIZER28.6424.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
70
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation FAIR 40
Growth STRONG 78
Profitability DECENT 68
Technicals NEUTRAL 52
Risk LOW 80
Key Stats
TTM PE
30.98
P/B
5.39
52W HIGH
₹3602.0
OFF HIGH
-19.49%
DIV YIELD
0.06%
MKT CAP
₹1804 Cr
◉ Active Signals
MACDBearish-10.4013
RSI(14)Neutral46.14
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NGLFINE and at what entry.

Sign up freeSign in